Azafaros
Pre-clinicalAzafaros is supported by a syndicate of leading Dutch and Swiss investors. Our clinical candidate, nizubaglustat, is an orally available azasugar designed to treat the central nervous system and to interfere with the metabolism of glycosphingolipids affecting key disease pathways through a unique dual mode of action.
Founded
2018
Focus
Small Molecules
About
Azafaros is supported by a syndicate of leading Dutch and Swiss investors. Our clinical candidate, nizubaglustat, is an orally available azasugar designed to treat the central nervous system and to interfere with the metabolism of glycosphingolipids affecting key disease pathways through a unique dual mode of action.
Funding History
2Total raised: $35M
Series A$30MForbionSep 15, 2021
Seed$5MBioGeneration VenturesJun 15, 2019
Company Info
TypePrivate
Founded2018
LocationLeiden, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile